Tag: diffuse large B-cell lymphoma

Genmab gets EPKINLY FDA approval for diffuse large B-cell lymphoma

businessnewstoday- May 21, 2023

Danish biotech company Genmab has secured accelerated approval for EPKINLY (epcoritamab-bysp) from the US Food and Drug Administration (FDA) for the treatment of relapsed or ... Read More

Merck to acquire US biopharma company VelosBio to strengthen oncology pipeline

pharmanewsdaily- November 8, 2020

Merck acquisition of VelosBio : US pharma giant Merck has agreed to acquire VelosBio, a California-based clinical-stage biopharma company, for $2.75 billion in an all-cash ... Read More

Gilead Sciences to acquire immuno-oncology company Forty Seven for $4.9bn

pharmanewsdaily- March 3, 2020

Gilead Sciences acquisition of Forty Seven : US biotech company Gilead Sciences has signed an all-cash deal worth around $4.9 billion to acquire Forty Seven, ... Read More

Denovo Biopharma gets FDA approval to launch phase 2b GBM trial for DB102

pharmanewsdaily- October 16, 2019

Denovo Biopharma has secured approval from the US Food and Drug Administration (FDA) to launch its phase 2b clinical trial of DB102 in patients with ... Read More